Professional Documents
Culture Documents
| BS EN
|
|
|
12687:1998
|
|
|
|
|
|
|
|
|
|
|
|
|
Biotechnology Ð Modified |
|
|
|
organisms for application in |
|
|
|
|
the environment Ð Guidance |
|
|
|
for the characterization of the |
|
|
|
|
genetically modified organism |
|
|
|
by analysis of the genomic |
|
|
|
|
modification |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
--`,`,-`-`,,`,,`,`,,`---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The European Standard EN 12687:1998 has the status of a |
British Standard |
|
|
|
|
|
|
|
|
ICS 07.080; |
|
|
|
|
|
|
|
|
NO COPYING WITHOUT BSI PERMISSION EXCEPT AS PERMITTED BY COPYRIGHT LAW
|
|
|
|
Copyright British Standards Institution
Provided by IHS under license with BSI
No reproduction or networking permitted without license from IHS Not for Resale
BS EN 12687:1998
National foreword
This British Standard is the English language version of EN 12687:1998.
The UK participation in its preparation was entrusted to Technical Committee
CII/58, Biotechnology, which has the responsibility to:
Summary of pages
This document comprises a front cover, an inside front cover, the EN title page,
pages 2 to 9 and a back cover.
BSI 1998
ICS 07.080
Descriptors: biotechnology, genetics, modified organisms, environments, environmental protection, analysis methods, bioassay,
experimental design
English version
GenomveraÈnderung
CEN
European Committee for Standardization
Comite EuropeÂen de Normalisation
EuropaÈisches Komitee fuÈr Normung
1998 CEN All rights of exploitation in any form and by any means reserved worldwide for CEN national
Members.
Ref. No. EN 12687:1998 E
Foreword Contents
This European Standard has been prepared by Page
Technical Committee CEN/TC 233, Biotechnology, the
Secretariat of which is held by AFNOR. Foreword 2
This European Standard shall be given the status of a Introduction 3
national standard, either by publication of an identical 1 Scope 3
text or by endorsement, at the latest by January 1999, 2 Normative references 3
and conflicting national standards shall be withdrawn
at the latest by January 1999. 3 Definitions 3
This European Standard has been prepared under a 4 Testing for genomic modification 4
mandate given to CEN by the European Commission 5 Materials 4
and the European Free Trade Association.
6 Considerations for experimental
According to the CEN/CENELEC Internal Regulations, procedures 5
the national standards organizations of the following
countries are bound to implement this European 7 Validity of data analysis 7
Standard: Austria, Belgium, Czech Republic, Denmark, 8 Documentation of the results 8
Finland, France, Germany, Greece, Iceland, Ireland, Annex A (informative) Bibliography 9
Italy, Luxembourg, Netherlands, Norway, Portugal,
Spain, Sweden, Switzerland and the United Kingdom.
--`,`,-`-`,,`,,`,`,,`---
Introduction 3 Definitions
This European Standard relates to part of the For the purposes of this standard, the following
characterization of genetically modified organisms definitions apply:
(GMOs). It is designed as a guideline for the adaptation 3.1
of experimental procedures to the requirements of the
specific experimental design. The characterization of a control
GMO can include the analysis of: preparation of known characteristics used to
Ð the genomic modification; standardize an analysis
Ð the functional expression of the genomic 3.2
modification (see EN 12682); data signal
Ð the molecular stability of the genomic output of a test system
modification (see EN 12683). NOTE Data signals can be characterized:
This European Standard relates to the specific Ð by binary decision: presence/absence (+/2);
characterization of the genomic modification of GMOs. Ð in relative terms by ordering the data signal strength with
This characterization is implicit for use during respect to (a) defined control(s);
environmental releases and should be applied, if Ð quantitatively by giving their output strength in absolute
terms;
required, during assessment of product quality.
Ð by position or movement;
Ð qualitatively by describing parameters not addressed by
1 Scope strength or position.
--`,`,-`-`,,`,,`,`,,`---
4.1 General considerations 4.4 in-vitro DNA- or RNA-fragment amplification
A genetic modification in general is intended to modify method
the expression of genetic traits of an organism or to The DNA- or RNA-fragment amplification method is
produce a new gene product in a GMO, in order to used to obtain multiple copies (amplification) of a
modify the phenotype of that organism. The presence segment of DNA (template DNA) or RNA (template
of the genetic modification of interest as it exists in the RNA) that is located between regions of known
GMO can be deduced from the presence or absence of nucleotide sequence, which are complementary with
an insert of specific DNA or gene product(s) such as synthetic primers.
RNA or protein, of a specific biochemical reaction, or 4.5 Sequencing method
of a specific phenotypic trait (see EN 12682). Only the The methods for determination of nucleotide
analysis at the level of genetic material provides sequences can be used for:
information about the structure of the genetic
modification of interest within the GMO. Ð confirmation of sequence identity;
The methods described in this European Standard Ð confirmation of the sequence at the integration
relate to the detection and identification of a particular site;
GMO by determination of the presence of nucleic acid Ð characterization of the sequence flanking the
molecules which specifically characterizes the GMO. genomic modification.
Usually the genetic modification of interest is a DNA The determination of the sequence of the genomic
sequence. However, in some special cases, the genetic modification should not be considered as a necessity.
modification of interest can be a RNA sequence
(e.g. RNA-viruses). 5 Materials
Not all of the methods described in this European
5.1 Nucleic acid materials
Standard are necessarily applicable for every analysis
of the genetic modification of interest as it exists in the The test should be carried out on a nucleic acid target
GMO. This standard provides the criteria by which a from the samples and the controls. Depending on the
suitable method or combination of methods is found procedure and the experimental technique used, the
for the analysis of the genomic modification, requirement for quantity and purity of the extracted
depending on the purpose of the analysis. nucleic acids can be different. Special extraction
The methods described in this standard can be procedures can be required for different organisms
appropriate to test GMOs provided that the genetic (Gram-positive and Gram-negative bacteria, yeasts,
modification of interest is available either as cloned fungi, plant and animal cells). The extraction protocol
DNA, or as complete or partial nucleotide sequence should provide nucleic acid specimens of sufficient
data or other relevant data. They refer to techniques purity to ensure the reproducibility of the results.
that are based on: Important considerations for yield and purity of nucleic
acids are the method of cellular lysis, the removal of
a) restriction pattern analysis (see 4.2); cell debris, nucleases and hybridization inhibitors, and
b) DNA- or RNA-hybridization (see 4.3); the gentle handling of samples to minimize mechanical
c) DNA- or RNA-fragment amplification (see 4.4); shearing of long DNA molecules. The nucleic acid
d) DNA- or RNA-sequencing of the genomic isolated from test samples and controls should ideally
modification (see 4.5). be prepared using the same procedure.
A gene probe is more specific if it is limited to a this analysis followed by the design of the experiment,
portion of the genomic modification rather than the which should be written down in a protocol, but
entire genomic modification to reduce the potential for keeping the flexibility needed to handle unexpected
cross-hybridization or non-specific hybridization. observations.
Hybridization conditions involving short The experimental design to analyse the genomic
oligonucleotides can be chosen such that a single modification should take into consideration the
nucleotide mismatch prevents the pairing of the following:
nucleotide strands, thus increasing the specificity. In Ð final objective of the analysis;
designing a gene probe the following criteria should be Ð type of analysis (detection and/or identification of
considered: a GMO, presence of genetic modification of interest,
Ð guanine plus cytosine content; determination of copy number and insertion site(s));
Ð self-complementarity; Ð choice of the method(s);
Ð uniqueness of the sequence; Ð type of organism (micro-organism, plant, animal);
Ð length of the sequence; Ð type of genetic modification (deletion,
Ð type of nucleic acid. substitution, insertion);
In general, it should be noted that the sensitivity of a Ð part of the organism used for analysis;
method using short gene probes is lower than that of a Ð type of nucleic acid to be tested;
method using longer gene probes because they Ð number of samples needed for statistical
incorporate fewer labelled nucleotides per hybrid. confidence;
Sensitivity sometimes can be improved by using single
Ð use of appropriate controls.
stranded RNA- or DNA-gene probes thus reducing NOTE This list should not be considered exhaustive.
self-annealing.
6.3 Execution of the experimental protocol
5.3 Labelling techniques of the gene probe
Guidance on choice of label and appropriate methods 6.3.1 General
for incorporation of label into the gene probe can be The following is a list of methods appropriate to
found in any current technical manual (see annex A [3]). specifically detect and identify the genomic
If appropriate, validated methods should be used. modification at the DNA or RNA level. Not all of these
In determining the choice of label and the labelling methods are necessarily applicable for the analysis of
technique, it is important to consider the following every genomic modification. The method of choice and
points: its appropriateness or combination of methods
Ð efficacy; depends on the stated objectives of the analysis. As
Ð shelf life or half-life of the labelled gene probe; molecular biology is a rapidly evolving field of
research, the listed methods are considered neither
Ð availability and costs of appropriate areas and
prioritized, restrictive nor exhaustive. The methods
equipment;
should be properly assessed with regard to their
Ð costs for training of personnel; information value:
Ð availability and costs of labelling material. a) restriction pattern analysis;
b) nucleic acid hybridization methods;
6 Considerations for experimental c) nucleic acid amplification methods;
procedures d) sequencing methods.
6.1 General 6.3.2 Restriction pattern analysis
The main steps of the experimental procedures for the The alteration in fragment length or presence or
analysis of the genomic modification are: absence of inserted DNA can be detected by digestion
a) precise statement of the objective for the intended of the isolated DNA with one or a combination of
analysis (see 6.2); restriction enzymes, followed by fractionating DNA
b) experimental design according to various criteria fragments according to size and visualizing by
(see 6.2); appropriate means.
6.3.3 Nucleic acid hybridization methods The specificity of the technique depends mainly on
In preparation of the hybridization assay the nucleic the gene probe used and the nature of target nucleic
acid should be transferred and fixed onto a solid acid. The limit of detection is determined by the
support (membrane or other material). Alternatively, amount of sample DNA or RNA and the specific
hybridization assay can be performed in solution. The activity of label of the gene probe.
different transfer procedures and starting materials are False positive hybridization data signals are
reflected in the designation of the following relevant recognized if a fragment other than the size
techniques. predicted from the genetic modification of interest is
a) Slot/dot blot analysis detected by the gene probe. However in this case, it
is also possible that the genomic modification had
These techniques are suitable for screening samples
undergone a rearrangement.
to qualitatively detect the presence or absence of the
genetic modification of interest. Quantification can If the DNA or RNA to be detected in the positive
be achieved through the use of a densitometer or control is originally derived from a genetically
liquid scintillation counting. However, false positive modified micro-organism (i.e. phage vectors,
data signals can result from the presence of closely conjugating bacteria or viruses), this DNA/RNA
related sequences, since these techniques detect should ideally be isolated and analysed by the same
nucleic acid in batch and closely related sequences procedure and evaluated by the same criteria as
can react. If these sequences are size fractionated nucleic acid of the final GMO.
[see 6.3.3c], the false positive data signal often can A positive control for hybridization will be obtained
no longer be detected. by restriction of the DNA fragment containing the
b) Colony, plaque and cytological hybridization genetic modification of interest with a restriction
enzyme or set of enzymes having at least two cutting
This hybridization technique allows the screening of
sites in this fragment. The patterns obtained after
individual clones. It should be used when
separation by gel electrophoresis should be
conventional culturing techniques are insufficient to
compared with DNA marker fragments of known
identify the GMO.
size and/or by comparison with a restriction map of
The conditions for hybridization and stringency of the original donor DNA.
washing should be adapted to the gene probe used.
A negative control should be obtained by using the
The specificity of the technique depends on the
nucleic acid of an organism which is identical to the
ability of the gene probe to discriminate between the
GMO except for the lack of the sequence of interest,
target sequence, cross-reacting sequences and
(e.g. DNA/RNA of recipient or parental organism).
material. Because of carry-over of components of
culture media on the hybridization membrane such d) Solution hybridization
as salts and impurities from cell-lysis, artifactual data Hybridization proceeds in solution before the gene
signals can arise which can be misinterpreted as probe-target duplex is captured for identification
positive. To identify artifacts it is often necessary to and/or quantification. Because the target is not fixed
hybridize duplicate filters. and thus is completely accessible to the gene probe,
The sensitivity of the technique is limited to the need hybridization in solution has the advantage of a
to cultivate the organisms. higher sensitivity.
The advantage of the technique is that large numbers Care should be taken because the gene probe-DNA
of colonies can be screened simultaneously, thus can reassociate (see annex A [3]). In this case, it may
saving time. Only a small amount of sample be difficult to separate gene probe-target hybrids
preparation is necessary without the need to purify from the self-annealed gene probe. Also, non-specific
the nucleic acid. binding of the gene probe to sequences with partial
homology can generate false positive data signals.
c) Southern and Northern hybridization
This technique permits the use of large amounts of
Southern and Northern blot analysis is usually used
DNA which can be necessary if the concentration of
for verification and diagnosis rather than for large
the target DNA in the sample is low.
scale screening. By this technique, single strains or
varieties can be identified, as well as e) In situ hybridization
rearrangements, deletions, gene transfer and the This technique allows the detection and
copy number of the genetic modification of interest identification of individual whole cells in samples
in the genome. The conditions for hybridization and containing mixed population(s) and the analysis of
stringency of washing should be adapted to the gene their spatial distribution. Whole cells, which are
probe used and the nature of hybridization made permeable to labelled gene probes, can be
membranes. visualized after hybridization. This technique can
also be applied to chromosomal spreads (FISH:
fluorescent in situ hybridization).
--`,`,-`-`,,`,,`,`,,`---
--`,`,-`-`,,`,,`,`,,`---
A positive control with respect to hybridization A positive control with respect to the amplification
analysis consists of a mixed sample combining both procedure consists of a nucleic acid sample of the
total nucleic acid extracted from non-modified recipient organism to which the modified sequence of
organism(s) and the appropriate fragments of the interest is added as purified nucleic acid.
modified nucleic acid of interest. As a result, positive A negative control with respect to the amplification
hybridization data signals should show up at positions procedure consists of a nucleic acid sample of the
of the expected relative molecular mass. If additional recipient organism, which does not contain the
bands are visualized by this protocol, this could mean sequence involved in genomic modification.
that non-specific hybridization exists between total
nucleic acid and the gene probes, or that 7.2.3 Validity of data analysis based on the
contamination has occurred during sample preparation. sequencing methods
A negative control with respect to hybridization The sequence should be clearly readable from the
analysis consists of nucleic acid extracted from a visualized picture of the results of sequencing reaction.
non-modified organism. A positive hybridization data The use of a positive control should be included in the
signal demonstrates that non-specific hybridization can analysis.
occur with total non-modified nucleic acid, or that The determination of the sequence of only one strand
contamination of the sample has occurred. of the nucleic acid of the sequence of interest is
7.2.2 Validity of data analysis based on nucleic sufficient if the aim is to confirm sequence identity.
acid fragment amplification methods The differences of nucleotides should not exceed
normal sequencing artifacts of the enzymes used. If the
Using the amplification technique (e.g. PCR) the sequence is determined from an amplified nucleic acid,
sample(s) and both positive and negative controls the template DNA used for sequencing should be
should be amplified in parallel, and the amplification derived directly from amplification reaction.
reaction should be verified in order to avoid false
results. The position of the sequenced region should be
adequately determined by reference to well-known
Verification of false positive results can be done by restriction maps or by unequivocal identification of
testing a specimen without the target nucleic acid. sequence overlaps.
Verification of false negative results and the success of If the sequence is determined at integration sites to
the reaction can be done by simultaneous amplification verify the location of the fragment, the determined
of a second nucleic acid fragment of different size in sequence should be as anticipated.
the same sample which acts as an internal marker.
Such an internal marker can be a sequence of the The positive control consists of an already sequenced
genome of the recipient organism, or a foreign nucleic acid fragment.
sequence added to the nucleic acid to be analysed, as
well as the positive and negative controls. However, 8 Documentation of the results
this type of PCR control can alter the limit of The results should be documented in a comprehensible
detection. The primers used to amplify the internal form by films (e.g. autoradiographic films), photos of
marker should not give any amplification of the filters or gels, and by text indicating the results
genomic modification. If size separation techniques are obtained (conformity of the DNA intended, modified
used for detection, the length of the amplified fragment sequence present or not, estimated number of copies
of the internal marker should be similar to, but clearly or range of number of copies per genome or cell
distinguishable from the length of the amplified number) with reference to this European Standard,
fragment of the modified sequence. and indicating at least which technique was used. The
The comparison between positive and negative documentation of results should also include a
controls and between sample(s) and controls indicates description of the genetic modification of interest as it
the specificity of the analysis and whether the genetic exists in the GMO and a short written evaluation of the
modification of interest is present in the representative tests by the experimenter. The report should be kept in
samples. an identified location.
--`,`,-`-`,,`,,`,`,,`---
Annex A (informative)
Bibliography
[1] Council Directive 90/219/EEC of 23 April 1990 on
the contained use of genetically modified
micro-organisms. OJEC 08.05.1990, no. L 117, p 1.
[2] Council Directive 90/220/EEC of 23 April 1990 on
the deliberate release into the environment of
genetically modified organisms. OJEC 08.05.1990,
no. L 117, p 15.
[3] Ausubel, F.A. et al. (eds. Greene). Current
Protocols in Molecular Biology. Publ. Wiley &
Sons.
[4] EN 12305, Biotechnology Ð Modified organisms
for application in the environment Ð Guidance
for the sampling strategies for deliberate releases
of genetically modified plants.
[5] EN 12686, Biotechnology Ð Modified organisms
for application in the environment Ð Guidance
for the sampling strategies for deliberate releases
of genetically modified micro-organisms,
including viruses.
--`,`,-`-`,,`,,`,`,,`---
[6] Sambrook J., Fritsch E.F. and Maniatis T. (1989).
Molecular Cloning. A Laboratory Manual, Second
Edition, Cold Spring Harbor Laboratory Press.